HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Federated/May retail giant

This article was originally published in The Rose Sheet

Executive Summary

Federated Department Stores agrees to buy The May Department Stores Company for $11 bil. in stock, creating a $30 bil. national department store giant that will change the face of prestige retailing. Firms announced the deal, which includes assumption of May's $6 mil. debt, Feb. 28. Closing is anticipated in Q3, after which Federated will operate 950 department stores and 700 bridal and formalwear stores, including May chains like Lord & Taylor, Filene's, Marshall Field's and Hecht's in addition to its own Macy's, Bloomingdale's, Burdines-Macy's and Rich's-Macy's. Merger will improve Federated's national marketing initiatives and offer better merchandise assortment at more competitive prices, firm says. Most of May's regional department stores will be converted to the Macy's nameplate. Federated has begun converting its own regional department stores to the Macy's name. Cost synergies from the acquisition are expected to be $175 mil. in 2006 and $450 mil. in 2007, and deal will be accretive to earnings in 2007...

You may also be interested in...



News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR

This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.

Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups

Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.

Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development

Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012870

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel